Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022)
Iridex's (IRIX) quarterly Long-Term Deferred Tax came in at $80000.0 in Q4 2022, up 220.0% year-on-year from $25000.0 in Q4 2021, and up 220.0% quarter-over-quarter from $25000.0 in Q1 2022.
Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022) Analysis & Trends
Iridex's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $80000.0 for Q4 2022.
- On a quarterly basis, Long-Term Deferred Tax rose 220.0% year-over-year to $80000.0 in Q4 2022; TTM through Dec 2022 was $80000.0, a 220.0% increase from a year earlier, with the FY2022 full-year figure at $80000.0, up 220.0% from the prior year.
- Long-Term Deferred Tax climbed to $80000.0 in Q4 2022 per IRIX's latest filing, from $25000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $80000.0 in Q4 2022 and bottomed at $25000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 80,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 1, 2016 | 8.99 Mn |
| Jul 2, 2016 | 8.99 Mn |
| Apr 2, 2016 | 8.99 Mn |
| Jan 2, 2016 | 8.99 Mn |
| Oct 3, 2015 | 7.15 Mn |
| Jul 4, 2015 | 7.15 Mn |
| Apr 4, 2015 | 7.00 Mn |
| Jan 3, 2015 | 7.15 Mn |
| Dec 28, 2013 | 10.00 Mn |
| Dec 29, 2012 | 10.10 Mn |
| Dec 31, 2011 | 11.70 Mn |